<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="39124">Calcium ion</z:chebi> participates in the regulation of neural transmission and the presynaptic release of <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>It is also involved in <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> events, <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> and abnormal conduction of stimuli </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of the present study was to evaluate the effects of <z:chebi fb="1" ids="7565">nifedipine</z:chebi>, a <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi>, on <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> and on reperfusion <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in rats prone to audiogenic <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> (Wistar audiogenic rats, WAR) and in <z:mpath ids='MPATH_458'>normal</z:mpath> Wistar rats (N = 6/group) </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:hpo ids='HP_0001250'>seizure</z:hpo> severity index was applied after an intraperitoneal injection of 20 or 40 mg/kg <z:chebi fb="1" ids="7565">nifedipine</z:chebi> (N20 and N40 groups, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>The Langendorff technique was used to analyze cardiac function, as well as the incidence and severity of the reperfusion <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> after ligature and release of the left coronary artery in rats treated or not with <z:chebi fb="1" ids="7565">nifedipine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>We found that <z:chebi fb="1" ids="7565">nifedipine</z:chebi> treatment decreased <z:hpo ids='HP_0001250'>seizure</z:hpo> severity (0.94 ± 0.02 for WAR; 0.70 ± 0.10 for WAR + N20; 0.47 ± 0.08 for WAR + N40) and increased the latent period (13 ± 2 s for WAR; 35 ± 10 s for WAR + N20; 48 ± 7 s for WAR + N40) for the development of <z:hpo ids='HP_0001250'>seizures</z:hpo> in WAR </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, the incidence and severity of the reperfusion <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> were lower in WAR and <z:mpath ids='MPATH_458'>normal</z:mpath> Wistar rats injected with <z:chebi fb="1" ids="7565">nifedipine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In WAR, these effects were mediated, at least in part, by a decrease in heart rate </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, our results indicate that <z:chebi fb="1" ids="7565">nifedipine</z:chebi> may be considered to be a potential adjuvant drug for <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> treatment, especially in those cases associated with cardiac rhythm abnormalities </plain></SENT>
</text></document>